GuangYuYuan Chinese Herbal Medicine Co., Ltd. (600771.SS)
CNY 19.33
(1.52%)
CNY 19.33
(1.52%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 32.59 Million CNY | -82.53% |
| 2022 | 186.53 Million CNY | 2.09% |
| 2021 | 182.71 Million CNY | 415.72% |
| 2020 | -57.87 Million CNY | 10.84% |
| 2019 | -64.9 Million CNY | -197.77% |
| 2018 | 66.38 Million CNY | 138.84% |
| 2017 | -170.94 Million CNY | 81.56% |
| 2016 | -927.13 Million CNY | -92.89% |
| 2015 | -480.65 Million CNY | -21218.84% |
| 2014 | 2.27 Million CNY | 109.69% |
| 2013 | -23.49 Million CNY | -313.75% |
| 2012 | 10.99 Million CNY | -98.12% |
| 2011 | 583.26 Million CNY | 62.77% |
| 2010 | 358.33 Million CNY | -55.29% |
| 2009 | 801.43 Million CNY | -3.09% |
| 2008 | 826.95 Million CNY | -11.24% |
| 2007 | 931.67 Million CNY | 13.12% |
| 2006 | 823.63 Million CNY | -14.21% |
| 2005 | 960.02 Million CNY | 50.04% |
| 2004 | 639.84 Million CNY | 15.2% |
| 2003 | 555.42 Million CNY | 247.64% |
| 2002 | 159.77 Million CNY | -31.39% |
| 2001 | 232.86 Million CNY | 111.94% |
| 2000 | 109.87 Million CNY | 98.16% |
| 1999 | 55.44 Million CNY | 13.07% |
| 1998 | 49.03 Million CNY | 14.33% |
| 1997 | 42.89 Million CNY | 40.21% |
| 1996 | 30.59 Million CNY | -9.34% |
| 1995 | 33.74 Million CNY | 21.58% |
| 1994 | 27.75 Million CNY | 39.16% |
| 1993 | 19.94 Million CNY | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q3 | -132.33 Million CNY | -11.17% |
| 2024 Q2 | -88.27 Million CNY | 7.51% |
| 2024 Q1 | -95.44 Million CNY | -392.8% |
| 2023 FY | 32.59 Million CNY | -82.53% |
| 2023 Q3 | 60.1 Million CNY | 16.23% |
| 2023 Q1 | 180.49 Million CNY | -3.24% |
| 2023 Q4 | 32.59 Million CNY | -45.77% |
| 2023 Q2 | 51.71 Million CNY | -71.35% |
| 2022 Q3 | 330.35 Million CNY | 26.97% |
| 2022 FY | 186.53 Million CNY | 2.09% |
| 2022 Q1 | 159.31 Million CNY | -12.8% |
| 2022 Q2 | 260.17 Million CNY | 63.3% |
| 2022 Q4 | 186.53 Million CNY | -43.53% |
| 2021 Q3 | 187.16 Million CNY | 17.96% |
| 2021 Q1 | 81.65 Million CNY | 241.09% |
| 2021 FY | 182.71 Million CNY | 415.72% |
| 2021 Q4 | 182.71 Million CNY | -2.38% |
| 2021 Q2 | 158.66 Million CNY | 94.32% |
| 2020 Q2 | -148.87 Million CNY | -16.91% |
| 2020 Q3 | -41.28 Million CNY | 72.27% |
| 2020 Q4 | -57.87 Million CNY | -40.17% |
| 2020 Q1 | -127.34 Million CNY | -96.2% |
| 2020 FY | -57.87 Million CNY | 10.84% |
| 2019 Q1 | 157.48 Million CNY | 137.22% |
| 2019 Q2 | 127.52 Million CNY | -19.02% |
| 2019 Q4 | -64.9 Million CNY | -159.11% |
| 2019 FY | -64.9 Million CNY | -197.77% |
| 2019 Q3 | 109.81 Million CNY | -13.89% |
| 2018 Q4 | 66.38 Million CNY | 750.23% |
| 2018 FY | 66.38 Million CNY | 138.84% |
| 2018 Q3 | -10.21 Million CNY | 92.12% |
| 2018 Q1 | -335.33 Million CNY | -96.16% |
| 2018 Q2 | -129.61 Million CNY | 61.35% |
| 2017 Q4 | -170.94 Million CNY | 19.22% |
| 2017 FY | -170.94 Million CNY | 81.56% |
| 2017 Q3 | -211.62 Million CNY | 26.92% |
| 2017 Q2 | -289.58 Million CNY | 22.79% |
| 2017 Q1 | -375.05 Million CNY | 59.55% |
| 2016 Q1 | -104.03 Million CNY | 78.36% |
| 2016 Q4 | -927.13 Million CNY | -342.51% |
| 2016 FY | -927.13 Million CNY | -92.89% |
| 2016 Q2 | -48.67 Million CNY | 53.21% |
| 2016 Q3 | -209.51 Million CNY | -330.43% |
| 2015 FY | -480.65 Million CNY | -21218.84% |
| 2015 Q2 | 12.01 Million CNY | 234.46% |
| 2015 Q4 | -480.65 Million CNY | -380.24% |
| 2015 Q3 | -100.08 Million CNY | -933.24% |
| 2015 Q1 | 3.59 Million CNY | 57.8% |
| 2014 FY | 2.27 Million CNY | 109.69% |
| 2014 Q1 | 3.39 Million CNY | 114.46% |
| 2014 Q4 | 2.27 Million CNY | -35.83% |
| 2014 Q2 | 7.03 Million CNY | 107.14% |
| 2014 Q3 | 3.54 Million CNY | -49.61% |
| 2013 Q3 | -3.94 Million CNY | -194.71% |
| 2013 Q4 | -23.49 Million CNY | -496.3% |
| 2013 Q1 | 13.76 Million CNY | 25.26% |
| 2013 FY | -23.49 Million CNY | -313.75% |
| 2013 Q2 | 4.16 Million CNY | -69.78% |
| 2012 FY | 10.99 Million CNY | -98.12% |
| 2012 Q4 | 10.99 Million CNY | -98.15% |
| 2012 Q3 | 593.9 Million CNY | 1.6% |
| 2012 Q2 | 584.55 Million CNY | 0.01% |
| 2012 Q1 | 584.49 Million CNY | 0.21% |
| 2011 Q1 | 446.85 Million CNY | 24.7% |
| 2011 Q2 | 540.97 Million CNY | 21.06% |
| 2011 Q3 | 579.42 Million CNY | 7.11% |
| 2011 Q4 | 583.26 Million CNY | 0.66% |
| 2011 FY | 583.26 Million CNY | 62.77% |
| 2010 Q2 | 746.24 Million CNY | -7.06% |
| 2010 FY | 358.33 Million CNY | -55.29% |
| 2010 Q1 | 802.89 Million CNY | 0.18% |
| 2010 Q4 | 358.33 Million CNY | -53.17% |
| 2010 Q3 | 765.22 Million CNY | 2.54% |
| 2009 Q1 | 857.89 Million CNY | 3.74% |
| 2009 Q3 | 854.77 Million CNY | -0.5% |
| 2009 Q4 | 801.43 Million CNY | -6.24% |
| 2009 Q2 | 859.05 Million CNY | 0.13% |
| 2009 FY | 801.43 Million CNY | -3.09% |
| 2008 Q1 | 935.12 Million CNY | 0.37% |
| 2008 Q3 | 564.89 Million CNY | -41.21% |
| 2008 Q4 | 826.95 Million CNY | 46.39% |
| 2008 FY | 826.95 Million CNY | -11.24% |
| 2008 Q2 | 960.79 Million CNY | 2.74% |
| 2007 Q2 | 865.08 Million CNY | -0.43% |
| 2007 Q4 | 931.67 Million CNY | 23.7% |
| 2007 FY | 931.67 Million CNY | 13.12% |
| 2007 Q1 | 868.85 Million CNY | 5.49% |
| 2007 Q3 | 753.15 Million CNY | -12.94% |
| 2006 FY | 823.63 Million CNY | -14.21% |
| 2006 Q1 | -103.63 Million CNY | -110.79% |
| 2006 Q4 | 823.63 Million CNY | -12.04% |
| 2006 Q3 | 936.34 Million CNY | 875.98% |
| 2006 Q2 | -120.66 Million CNY | -16.44% |
| 2005 Q3 | 103.37 Million CNY | -65.93% |
| 2005 Q2 | 303.39 Million CNY | 74.03% |
| 2005 Q1 | 174.33 Million CNY | -72.75% |
| 2005 FY | 960.02 Million CNY | 50.04% |
| 2005 Q4 | 960.02 Million CNY | 828.72% |
| 2004 FY | 639.84 Million CNY | 15.2% |
| 2004 Q1 | 209.45 Million CNY | -62.29% |
| 2004 Q3 | 199.86 Million CNY | -7.02% |
| 2004 Q4 | 639.84 Million CNY | 220.14% |
| 2004 Q2 | 214.94 Million CNY | 2.62% |
| 2003 FY | 555.42 Million CNY | 247.64% |
| 2003 Q1 | 198.82 Million CNY | 24.44% |
| 2003 Q2 | 250.49 Million CNY | 25.99% |
| 2003 Q3 | 301.83 Million CNY | 20.49% |
| 2003 Q4 | 555.42 Million CNY | 84.01% |
| 2002 FY | 159.77 Million CNY | -31.39% |
| 2002 Q1 | 222.63 Million CNY | -4.39% |
| 2002 Q2 | 234.04 Million CNY | 5.12% |
| 2002 Q3 | 174.81 Million CNY | -25.31% |
| 2002 Q4 | 159.77 Million CNY | -8.6% |
| 2001 Q2 | 133.9 Million CNY | 0.0% |
| 2001 FY | 232.86 Million CNY | 111.94% |
| 2001 Q4 | 232.86 Million CNY | 0.0% |
| 2000 Q2 | 65.21 Million CNY | 0.0% |
| 2000 Q4 | 109.87 Million CNY | 0.0% |
| 2000 FY | 109.87 Million CNY | 98.16% |
| 1999 FY | 55.44 Million CNY | 13.07% |
| 1999 Q2 | 17.34 Million CNY | 0.0% |
| 1999 Q4 | 55.44 Million CNY | 0.0% |
| 1998 FY | 49.03 Million CNY | 14.33% |
| 1998 Q4 | 49.03 Million CNY | 0.0% |
| 1998 Q2 | 54.38 Million CNY | 0.0% |
| 1997 Q2 | - CNY | 0.0% |
| 1997 FY | 42.89 Million CNY | 40.21% |
| 1997 Q4 | 42.89 Million CNY | 0.0% |
| 1996 Q4 | 30.59 Million CNY | 0.0% |
| 1996 FY | 30.59 Million CNY | -9.34% |
| 1995 FY | 33.74 Million CNY | 21.58% |
| 1994 FY | 27.75 Million CNY | 39.16% |
| 1993 FY | 19.94 Million CNY | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Jiangsu Hengrui Medicine Co., Ltd. | -20.67 Billion CNY | 100.158% |
| Zhangzhou Pientzehuang Pharmaceutical., Ltd | 248.15 Million CNY | 86.864% |
| Zhejiang CONBA Pharmaceutical Co.,Ltd. | -1.53 Billion CNY | 102.125% |
| Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd. | -309.42 Million CNY | 110.534% |
| Aurora Optoelectronics Co.,Ltd. | -251.17 Million CNY | 112.978% |
| Hangzhou TianMuShan Pharmaceutical Enterprise Co.,Ltd | 16.8 Million CNY | -93.982% |
| NanJing Pharmaceutical Company Limited | 9.24 Billion CNY | 99.647% |
| Tonghua Dongbao Pharmaceutical Co., Ltd. | -954.2 Million CNY | 103.416% |